TGF-beta-dependent and -independent roles of STRAP in cancer

Frontiers in Bioscience

Volumn 16, Issue 1, 2011, Pages 105-115

  Reiner, Jennifer Elisabeth ^a   Datta, Pran K ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Cancer; Review; Smad signaling; STRAP; TGF beta

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; CALMODULIN BINDING PROTEIN; EWSR1 PROTEIN, HUMAN; INHIBITORY SMAD PROTEIN; MESSENGER RNA; NUCLEOSIDE DIPHOSPHATE KINASE NM23; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN SERINE THREONINE KINASE; PYRUVATE DEHYDROGENASE (ACETYL TRANSFERRING) KINASE; PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE; RNA BINDING PROTEIN; SMAD PROTEIN; STRAP PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; DRUG EFFECT; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; METABOLISM; MOUSE; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

ANIMALS; CALMODULIN-BINDING PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MAP KINASE KINASE KINASE 5; MICE; NEOPLASMS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RNA, MESSENGER; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; SMAD PROTEINS; SMAD PROTEINS, INHIBITORY; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 79954991040     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3678     Document Type: Article

References (82)

1. Halder, S. K., G. Anumanthan, R. Maddula, J. Mann, A. Chytil, A. L. Gonzalez, M. K. Washington, H. L. Moses, R. D. Beauchamp & P. K. Datta: Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis. Cancer Res, 66, 6156-66 (2006)
2. Matsuda, S., R. Katsumata, T. Okuda, T. Yamamoto, K. Miyazaki, T. Senga, K. Machida, A. A. Thant, S. Nakatsugawa & M. Hamaguchi: Molecular cloning and characterization of human MAWD, a novel protein containing WD-40 repeats frequently overexpressed in breast cancer. Cancer Res, 60, 13-7 (2000) (Pubitemid 30058721)
3. Khokhar, A., N. Chen, J. P. Yuan, Y. Li, G. N. Landis, G. Beaulieu, H. Kaur & J. Tower: Conditional switches for extracellular matrix patterning in Drosophila melanogaster. Genetics, 178, 1283-93 (2008)
4. Chen, W. V., J. Delrow, P. D. Corrin, J. P. Frazier & P. Soriano: Identification and validation of PDGF transcriptional targets by microarray-coupled gene-trap mutagenesis. Nat Genet, 36, 304-12 (2004) (Pubitemid 38282758)
5. Li, D. & R. Roberts: WD-repeat proteins: structure characteristics, biological function, and their involvement in human diseases. Cell Mol Life Sci, 58, 2085-97 (2001) (Pubitemid 34016977)
6. Derynck, R. & Y. E. Zhang: Smad-dependent and Smadindependent pathways in TGF-beta family signalling. Nature, 425, 577-84 (2003) (Pubitemid 37280136)
7. Engel, M. E., P. K. Datta & H. L. Moses: Signal transduction by transforming growth factor-beta: a cooperative paradigm with extensive negative regulation. J Cell Biochem Suppl, 30-31, 111-22 (1998) (Pubitemid 29028732)
8. Nakao, A., E. Roijer, T. Imamura, S. Souchelnytskyi, G. Stenman, C. H. Heldin & P. ten Dijke: Identification of Smad2, a human Mad-related protein in the transforming growth factor beta signaling pathway. J Biol Chem, 272, 2896-900 (1997) (Pubitemid 27053339)
9. Lagna, G., A. Hata, A. Hemmati-Brivanlou & J. Massague: Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature, 383, 832-6 (1996) (Pubitemid 26372668)
10. Zhang, Y., X. Feng, R. We & R. Derynck: Receptorassociated Mad homologues synergize as effectors of the TGF-beta response. Nature, 383, 168-72 (1996) (Pubitemid 26303979)
11. Kretzschmar, M. & J. Massague: SMADs: mediators and regulators of TGF-beta signaling. Curr Opin Genet Dev, 8, 103-11 (1998) (Pubitemid 28122148)
12. Sirard, C., S. Kim, C. Mirtsos, P. Tadich, P. A. Hoodless, A. Itie, R. Maxson, J. L. Wrana & T. W. Mak: Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor betarelated signaling. J Biol Chem, 275, 2063-70 (2000) (Pubitemid 30060834)
13. Yan, Z., G. Y. Kim, X. Deng & E. Friedman: Transforming growth factor beta 1 induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1. J Biol Chem, 277, 9870-9 (2002) (Pubitemid 34968092)
14. Xie, L., B. K. Law, A. M. Chytil, K. A. Brown, M. E. Aakre & H. L. Moses: Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia, 6, 603-10 (2004) (Pubitemid 39411098)
15. Tavares, A. L., M. E. Mercado-Pimentel, R. B. Runyan & G. T. Kitten: TGF beta-mediated RhoA expression is necessary for epithelial-mesenchymal transition in the embryonic chick heart. Dev Dyn, 235, 1589-98 (2006) (Pubitemid 43787961)
16. Kim, J. S., J. G. Kim, M. Y. Moon, C. Y. Jeon, H. Y. Won, H. J. Kim, Y. J. Jeon, J. Y. Seo, J. I. Kim, J. Kim, J. Y. Lee, P. H. Kim & J. B. Park: Transforming growth factor-beta1 regulates macrophage migration via RhoA. Blood, 108, 1821-9 (2006) (Pubitemid 44394988)
17. Wang, S. E., B. Xiang, M. Guix, M. G. Olivares, J. Parker, C. H. Chung, A. Pandiella & C. L. Arteaga: Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab. Mol Cell Biol, 28, 5605-20 (2008)
18. Kattla, J. J., R. M. Carew, M. Heljic, C. Godson & D. P. Brazil: Protein kinase B/Akt activity is involved in renal TGF-beta1-driven epithelial-mesenchymal transition in vitro and in vivo. Am J Physiol Renal Physiol, 295, F215-25 (2008)
19. Yeh, Y. Y., C. C. Chiao, W. Y. Kuo, Y. C. Hsiao, Y. J. Chen, Y. Y. Wei, T. H. Lai, Y. C. Fong & C. H. Tang: TGF-beta1 increases motility and alphavbeta3 integrin up-regulation via PI3K, Akt and NF-kappaB-dependent pathway in human chondrosarcoma cells. Biochem Pharmacol, 75, 1292-301 (2008)
20. Yue, J., B. Sun, G. Liu & K. M. Mulder: Requirement of TGF-beta receptor-dependent activation of c-Jun Nterminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor. J Cell Physiol, 199, 284-92 (2004) (Pubitemid 38436755)
21. Bakin, A. V., A. Safina, C. Rinehart, C. Daroqui, H. Darbary & D. M. Helfman: A critical role of tropomyosins in TGF-beta regulation of the actin cytoskeleton and cell motility in epithelial cells. Mol Biol Cell, 15, 4682-94 (2004) (Pubitemid 39299114)
22. Erdogan, M., A. Pozzi, N. Bhowmick, H. L. Moses & R. Zent: Transforming growth factor-beta (TGF-beta) and TGF-beta-associated kinase 1 are required for R-Rasmediated transformation of mammary epithelial cells. Cancer Res, 68, 6224-31 (2008)
23. Fleming, Y. M., G. J. Ferguson, L. C. Spender, J. Larsson, S. Karlsson, B. W. Ozanne, R. Grosse & G. J. Inman: TGF-beta-mediated activation of RhoA signalling is required for efficient (V12)HaRas and (V600E)BRAF transformation. Oncogene, 28, 983-93 (2009)
24. Du, J., B. Jiang, R. J. Coffey & J. Barnard: Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta. Mol Cancer Res, 2, 233-41 (2004) (Pubitemid 39031084)
25. Nagaraj, N. S. & P. K. Datta: Targeting the transforming growth factor-beta signaling pathway in human cancer. Expert Opin Investig Drugs, 19, 77-91 (2010)
26. Nakao, A., M. Afrakhte, A. Moren, T. Nakayama, J. L. Christian, R. Heuchel, S. Itoh, M. Kawabata, N. E. Heldin, C. H. Heldin & P. ten Dijke: Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature, 389, 631-5 (1997) (Pubitemid 27446184)
27. Imamura, T., M. Takase, A. Nishihara, E. Oeda, J. Hanai, M. Kawabata & K. Miyazono: Smad6 inhibits signalling by the TGF-beta superfamily. Nature, 389, 622-6 (1997) (Pubitemid 27446182)
28. Choy, L. & R. Derynck: The type II transforming growth factor (TGF)-beta receptor-interacting protein TRIP-1 acts as a modulator of the TGF-beta response. J Biol Chem, 273, 31455-62 (1998) (Pubitemid 28533166)
29. Chen, R. H., P. J. Miettinen, E. M. Maruoka, L. Choy & R. Derynck: A WD-domain protein that is associated with and phosphorylated by the type II TGF-beta receptor. Nature, 377, 548-52 (1995)
30. Datta, P. K. & H. L. Moses: STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling. Mol Cell Biol, 20, 3157-67 (2000) (Pubitemid 30215028)
31. Halder, S. K., R. D. Beauchamp & P. K. Datta: Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis. Exp Cell Res, 307, 231-46 (2005) (Pubitemid 40732749)
32. Liu, Y., J. Wang, M. Wu, W. Wan, R. Sun, D. Yang, X. Sun, D. Ma, G. Ying & N. Zhang: Down-regulation of 3-phosphoinositide-dependent protein kinase-1 levels inhibits migration and experimental metastasis of human breast cancer cells. Mol Cancer Res, 7, 944-54 (2009)
33. Peifer, C. & D. R. Alessi: New anti-cancer role for PDK1 inhibitors: preventing resistance to tamoxifen. Biochem J, 417, e5-7 (2009)
34. Westmoreland, J. J., Q. Wang, M. Bouzaffour, S. J. Baker & B. Sosa-Pineda: Pdk1 activity controls proliferation, survival, and growth of developing pancreatic cells. Dev Biol, 334, 285-98 (2009)
35. Choi, J. H., Y. R. Yang, S. K. Lee, S. H. Kim, Y. H. Kim, J. Y. Cha, S. W. Oh, J. R. Ha, S. H. Ryu & P. G. Suh: Potential inhibition of PDK1/Akt signaling by phenothiazines suppresses cancer cell proliferation and survival. Ann N Y Acad Sci, 1138, 393-403 (2008)
36. Bayascas, J. R., N. R. Leslie, R. Parsons, S. Fleming & D. R. Alessi: Hypomorphic mutation of PDK1 suppresses tumorigenesis in PTEN (+/-) mice. Curr Biol, 15, 1839-46 (2005) (Pubitemid 41501519)
37. Garcia-Echeverria, C. & W. R. Sellers: Drug discovery approaches targeting the PI3K/Akt pathway in cancer. Oncogene, 27, 5511-26 (2008)
38. Barnett, S. F., D. Defeo-Jones, S. Fu, P. J. Hancock, K. M. Haskell, R. E. Jones, J. A. Kahana, A. M. Kral, K. Leander, L. L. Lee, J. Malinowski, E. M. McAvoy, D. D. Nahas, R. G. Robinson & H. E. Huber: Identification and characterization of pleckstrin-homology-domaindependent and isoenzyme-specific Akt inhibitors. Biochem J, 385, 399-408 (2005) (Pubitemid 40165072)
39. Seong, H. A., H. Jung, H. S. Choi, K. T. Kim & H. Ha: Regulation of transforming growth factor-beta signaling and PDK1 kinase activity by physical interaction between PDK1 and serine-threonine kinase receptor-associated protein. J Biol Chem, 280, 42897-908 (2005) (Pubitemid 43049252)
40. Seong, H. A., H. Jung, K. T. Kim & H. Ha: 3-Phosphoinositide- dependent PDK1 negatively regulates transforming growth factor-beta-induced signaling in a kinase-dependent manner through physical interaction with Smad proteins. J Biol Chem, 282, 12272-89 (2007) (Pubitemid 47100723)
41. Rosengard, A. M., H. C. Krutzsch, A. Shearn, J. R. Biggs, E. Barker, I. M. Margulies, C. R. King, L. A. Liotta & P. S. Steeg: Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development. Nature, 342, 177-80 (1989)
42. Leone, A., U. Flatow, C. R. King, M. A. Sandeen, I. M. Margulies, L. A. Liotta & P. S. Steeg: Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell, 65, 25-35 (1991) (Pubitemid 121001210)
43. Hennessy, C., J. A. Henry, F. E. May, B. R. Westley, B. Angus & T. W. Lennard: Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst, 83, 281-5 (1991)
44. Lombardi, D., E. Palescandolo, A. Giordano & M. G. Paggi: Interplay between the antimetastatic nm23 and the retinoblastoma-related Rb2/p130 genes in promoting neuronal differentiation of PC12 cells. Cell Death Differ, 8, 470-6 (2001) (Pubitemid 32492767)
45. Yang, Y., S. Lu, M. F. Li & Z. H. Wang: (Effects of tumor metastasis suppressor gene nm23-H1 on invasion and proliferation of cervical cancer cell lines.). Ai Zheng, 28, 702-7 (2009)
46. Leone, A., U. Flatow, K. VanHoutte & P. S. Steeg: Transfection of human nm23-H1 into the human MDAMB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene, 8, 2325-33 (1993) (Pubitemid 23252360)
47. Hsu, S., F. Huang, L. Wang, S. Banerjee, S. Winawer & E. Friedman: The role of nm23 in transforming growth factor beta 1-mediated adherence and growth arrest. Cell Growth Differ, 5, 909-17 (1994) (Pubitemid 24275105)
48. Seong, H. A., H. Jung & H. Ha: NM23-H1 tumor suppressor physically interacts with serine-threonine kinase receptor-associated protein, a transforming growth factorbeta (TGF-beta) receptor-interacting protein, and negatively regulates TGF-beta signaling. J Biol Chem, 282, 12075-96 (2007) (Pubitemid 47100716)
49. Jung, H., H. A. Seong & H. Ha: NM23-H1 tumor suppressor and its interacting partner STRAP activate p53 function. J Biol Chem, 282, 35293-307 (2007) (Pubitemid 350232484)
50. Cordenonsi, M., S. Dupont, S. Maretto, A. Insinga, C. Imbriano & S. Piccolo: Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads. Cell, 113, 301-14 (2003) (Pubitemid 36556113)
51. Janknecht, R.: EWS-ETS oncoproteins: the linchpins of Ewing tumors. Gene, 363, 1-14 (2005) (Pubitemid 41691887)
52. Li, H., W. Watford, C. Li, A. Parmelee, M. A. Bryant, C. Deng, J. O'Shea & S. B. Lee: Ewing sarcoma gene EWS is essential for meiosis and B lymphocyte development. J Clin Invest, 117, 1314-23 (2007) (Pubitemid 46718419)
53. May, W. A., M. L. Gishizky, S. L. Lessnick, L. B. Lunsford, B. C. Lewis, O. Delattre, J. Zucman, G. Thomas & C. T. Denny: Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci U S A, 90, 5752-6 (1993) (Pubitemid 23176240)
54. May, W. A., S. L. Lessnick, B. S. Braun, M. Klemsz, B. C. Lewis, L. B. Lunsford, R. Hromas & C. T. Denny: The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol, 13, 7393-8 (1993) (Pubitemid 23354263)
55. Ohno, T., V. N. Rao & E. S. Reddy: EWS/Fli-1 chimeric protein is a transcriptional activator. Cancer Res, 53, 5859-63 (1993) (Pubitemid 24006149)
56. Hahm, K. B., K. Cho, C. Lee, Y. H. Im, J. Chang, S. G. Choi, P. H. Sorensen, C. J. Thiele & S. J. Kim: Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat Genet, 23, 222-7 (1999) (Pubitemid 29455398)
57. Araya, N., K. Hirota, Y. Shimamoto, M. Miyagishi, E. Yoshida, J. Ishida, S. Kaneko, M. Kaneko, T. Nakajima & A. Fukamizu: Cooperative interaction of EWS with CREBbinding protein selectively activates hepatocyte nuclear factor 4-mediated transcription. J Biol Chem, 278, 5427-32 (2003) (Pubitemid 36801059)
58. Siligan, C., J. Ban, R. Bachmaier, L. Spahn, M. Kreppel, K. L. Schaefer, C. Poremba, D. N. Aryee & H. Kovar: EWSFLI1 target genes recovered from Ewing's sarcoma chromatin. Oncogene, 24, 2512-24 (2005) (Pubitemid 40593042)
59. Anumanthan, G., S. K. Halder, D. B. Friedman & P. K. Datta: Oncogenic serine-threonine kinase receptor-associated protein modulates the function of Ewing sarcoma protein through a novel mechanism. Cancer Res, 66, 10824-32 (2006) (Pubitemid 44876978)
60. Spath, G. F. & M. C. Weiss: Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes, acting as a morphogen in dedifferentiated hepatoma cells. J Cell Biol, 140, 935-46 (1998) (Pubitemid 28141230)
61. Lucas, B., K. Grigo, S. Erdmann, J. Lausen, L. Klein-Hitpass & G. U. Ryffel: HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma. Oncogene, 24, 6418-31 (2005) (Pubitemid 41486475)
62. Meurette, O., S. Stylianou, R. Rock, G. M. Collu, A. P. Gilmore & K. Brennan: Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells. Cancer Res, 69, 5015-22 (2009)
63. Kuo, C. T., B. C. Chen, C. C. Yu, C. M. Weng, M. J. Hsu, C. C. Chen, M. C. Chen, C. M. Teng, S. L. Pan, M. Y. Bien, C. H. Shih & C. H. Lin: Apoptosis signal-regulating kinase 1 mediates denbinobin-induced apoptosis in human lung adenocarcinoma cells. J Biomed Sci, 16, 43 (2009)
64. Jung, H., H. A. Seong, R. Manoharan & H. Ha: Serinethreonine kinase receptor-associated protein (STRAP) inhibits apoptosis signal-regulating kinase 1 function through direct interaction. J Biol Chem (2009)
65. Iriyama, T., K. Takeda, H. Nakamura, Y. Morimoto, T. Kuroiwa, J. Mizukami, T. Umeda, T. Noguchi, I. Naguro, H. Nishitoh, K. Saegusa, K. Tobiume, T. Homma, Y. Shimada, H. Tsuda, S. Aiko, I. Imoto, J. Inazawa, K. Chida, Y. Kamei, S. Kozuma, Y. Taketani, A. Matsuzawa & H. Ichijo: ASK1 and ASK2 differentially regulate the counteracting roles of apoptosis and inflammation in tumorigenesis. Embo J, 28, 843-53 (2009)
66. Kashikar, N. D., J. Reiner, A. Datta & P. K. Datta: Serine threonine receptor-associated protein (STRAP) plays a role in the maintenance of mesenchymal morphology. Cell Signal, 22, 138-49 (2009)
67. Hunt, S. L., J. J. Hsuan, N. Totty & R. J. Jackson: unr, a cellular cytoplasmic RNA-binding protein with five coldshock domains, is required for internal initiation of translation of human rhinovirus RNA. Genes Dev, 13, 437-48 (1999) (Pubitemid 29108759)
68. Evans, J. R., S. A. Mitchell, K. A. Spriggs, J. Ostrowski, K. Bomsztyk, D. Ostarek & A. E. Willis: Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene, 22, 8012-20 (2003) (Pubitemid 37175865)
69. Carissimi, C., J. Baccon, M. Straccia, P. Chiarella, A. Maiolica, A. Sawyer, J. Rappsilber & L. Pellizzoni: Unrip is a component of SMN complexes active in snRNP assembly. FEBS Lett, 579, 2348-54 (2005) (Pubitemid 40569503)
70. Grimmler, M., S. Otter, C. Peter, F. Muller, A. Chari & U. Fischer: Unrip, a factor implicated in cap-independent translation, associates with the cytosolic SMN complex and influences its intracellular localization. Hum Mol Genet, 14, 3099-111 (2005) (Pubitemid 41535474)
71. Guo, D., J. Han, B. L. Adam, N. H. Colburn, M. H. Wang, Z. Dong, D. L. Eizirik, J. X. She & C. Y. Wang: Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stress. Biochem Biophys Res Commun, 337, 1308-18 (2005) (Pubitemid 41505265)
72. Guo, D., M. Li, Y. Zhang, P. Yang, S. Eckenrode, D. Hopkins, W. Zheng, S. Purohit, R. H. Podolsky, A. Muir, J. Wang, Z. Dong, T. Brusko, M. Atkinson, P. Pozzilli, A. Zeidler, L. J. Raffel, C. O. Jacob, Y. Park, M. Serrano-Rios, M. T. Larrad, Z. Zhang, H. J. Garchon, J. F. Bach, J. I. Rotter, J. X. She & C. Y. Wang: A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet, 36, 837-41 (2004) (Pubitemid 39014100)
73. Bohren, K. M., V. Nadkarni, J. H. Song, K. H. Gabbay & D. Owerbach: A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J Biol Chem, 279, 27233-8 (2004) (Pubitemid 38812561)
74. Kim, C. J., B. J. Choi, J. H. Song, Y. K. Park, Y. G. Cho, S. W. Nam, N. J. Yoo, J. Y. Lee & W. S. Park: Overexpression of serine-threonine receptor kinaseassociated protein in colorectal cancers. Pathol Int, 57, 178-82 (2007) (Pubitemid 46279945)
75. Buess, M., L. Terracciano, J. Reuter, P. Ballabeni, J. L. Boulay, U. Laffer, U. Metzger, R. Herrmann & C. Rochlitz STRAP is a strong predictive marker of adjuvant chemotherapy benefit in colorectal cancer. Neoplasia, 6, 813-20 (2004) (Pubitemid 40041500)
76. Natrajan, R., M. B. Lambros, S. M. Rodriguez-Pinilla, G. Moreno-Bueno, D. S. Tan, C. Marchio, R. Vatcheva, S. Rayter, B. Mahler-Araujo, L. G. Fulford, D. Hungermann, A. Mackay, A. Grigoriadis, K. Fenwick, N. Tamber, D. Hardisson, A. Tutt, J. Palacios, C. J. Lord, H. Buerger, A. Ashworth & J. S. Reis-Filho: Tiling path genomic profiling of grade 3 invasive ductal breast cancers. Clin Cancer Res, 15, 2711-22 (2009)
77. Han, W., E. M. Jung, J. Cho, J. W. Lee, K. T. Hwang, S. J. Yang, J. J. Kang, J. Y. Bae, Y. K. Jeon, I. A. Park, M. Nicolau, S. S. Jeffrey & D. Y. Noh: DNA copy number alterations and expression of relevant genes in triplenegative breast cancer. Genes Chromosomes Cancer, 47, 490-9 (2008) (Pubitemid 351657184)
78. Poulos, C., L. Cheng, S. Zhang, D. J. Gersell & T. M. Ulbright: Analysis of ovarian teratomas for isochromosome 12p: evidence supporting a dual histogenetic pathway for teratomatous elements. Mod Pathol, 19, 766-71 (2006) (Pubitemid 43780445)
79. Henegariu, O., G. H. Vance, D. Heiber, M. Pera & N. A. Heerema: Triple-color FISH analysis of 12p amplification in testicular germ-cell tumors using 12p band-specific painting probes. J Mol Med, 76, 648-55 (1998) (Pubitemid 28361883)
80. Low, W. K., Y. Dang, T. Schneider-Poetsch, Z. Shi, N. S. Choi, R. M. Rzasa, H. A. Shea, S. Li, K. Park, G. Ma, D. Romo & J. O. Liu: Isolation and identification of eukaryotic initiation factor 4A as a molecular target for the marine natural product Pateamine A. Methods Enzymol, 431, 303-24 (2007)
81. Low, W. K., Y. Dang, T. Schneider-Poetsch, Z. Shi, N. S. Choi, W. C. Merrick, D. Romo & J. O. Liu: Inhibition of eukaryotic translation initiation by the marine natural product pateamine A. Mol Cell, 20, 709-22 (2005) (Pubitemid 41740693)
82. Kuznetsov, G., Q. Xu, L. Rudolph-Owen, K. Tendyke, J. Liu, M. Towle, N. Zhao, J. Marsh, S. Agoulnik, N. Twine, L. Parent, Z. Chen, J. L. Shie, Y. Jiang, H. Zhang, H. Du, R. Boivin, Y. Wang, D. Romo & B. A. Littlefield: Potent in vitro and in vivo anticancer activities of desmethyl, des-amino pateamine A, a synthetic analogue of marine natural product pateamine A. Mol Cancer Ther (2009)